Compugen Ltd (CGEN)

Jan 21, 2025

Compugen (NASDAQ:CGEN) Share Price Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World

Jan 21, 2025

Jan 21, 2025

Compugen (NASDAQ:CGEN) Share Price Crosses Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Jan 21, 2025

Jan 14, 2025

Has Compugen Ltd.'s (NASDAQ:CGEN) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - Simply Wall St

Jan 14, 2025

Jan 14, 2025

Compugen (NASDAQ:CGEN) Now Covered by Oppenheimer - Defense World

Jan 14, 2025

Jan 13, 2025

Compugen Ltd (NASDAQ: CGEN) Gains 3.14% In Early Trade; What Lies Ahead? - Stocks Register

Jan 13, 2025

Jan 13, 2025

Oppenheimer Initiates Coverage on Compugen (NASDAQ:CGEN) - MarketBeat

Jan 13, 2025

Jan 13, 2025

Oppenheimer starts Compugen at Outperform on immunotherapy candidates' potential By Investing.com - Investing.com Australia

Jan 13, 2025

Jan 13, 2025

Oppenheimer starts Compugen at Outperform on immunotherapy candidates' potential - Investing.com India

Jan 13, 2025

Jan 08, 2025

Compugen Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors - Marketscreener.com

Jan 08, 2025

Jan 08, 2025

Compugen Launches First-in-Class Cancer Trial with Novel IL-18 Antibody COM503 - StockTitan

Jan 08, 2025

Jan 01, 2025

Compugen Discloses Focused Target Discovery Program for Antibody-Drug Conjugate Cancer Therapy - AOL

Jan 01, 2025

Dec 26, 2024

The past five years for Compugen (NASDAQ:CGEN) investors has not been profitable - Yahoo Finance

Dec 26, 2024

Dec 11, 2024

Astrazeneca Plc ADR (AZN-Q) QuotePress Release - The Globe and Mail

Dec 11, 2024

Dec 11, 2024

Gilead Sciences Inc (GILD-Q) QuotePress Release - The Globe and Mail

Dec 11, 2024

Dec 06, 2024

Compugen (CGEN) Stock Surges Amid Biotech Industry Movement - GuruFocus.com

Dec 06, 2024

Nov 30, 2024

Connor Clark & Lunn Investment Management Ltd. Grows Position in Compugen Ltd. (NASDAQ:CGEN) - Defense World

Nov 30, 2024

Nov 27, 2024

Compugen Bolsters Cancer Therapy Portfolio with New Patent - TipRanks

Nov 27, 2024

Nov 27, 2024

Compugen Secures Key Patent for Triple Combination Cancer Immunotherapy Through 2037 | CGEN Stock News - StockTitan

Nov 27, 2024

Nov 24, 2024

Compugen Ltd. (NASDAQ:CGEN) Holdings Raised by Oppenheimer & Co. Inc. - Defense World

Nov 24, 2024

Nov 22, 2024

Compugen (CGEN) Stock Dips Amidst Biotech Sector Movements - GuruFocus.com

Nov 22, 2024

Nov 16, 2024

Compugen Ltd. (NASDAQ:CGEN) Short Interest Down 18.1% in October - MarketBeat

Nov 16, 2024

Nov 15, 2024

Compugen Ltd. (NASDAQ:CGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - Yahoo Finance

Nov 15, 2024

Nov 14, 2024

Compugen (CGEN) Stock Declines Amidst Industry Downtrend - GuruFocus.com

Nov 14, 2024

Nov 13, 2024

Compugen Ltd. (NASDAQ:CGEN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 13, 2024

Compugen Ltd (CGEN) Q3 2024 Earnings Call Highlights: Promising Developments and Strategic ... - Yahoo Finance

Nov 13, 2024

Nov 13, 2024

Compugen Ltd (CGEN) Q3 2024 Earnings Call Highlights: Promising Developments and Strategic ... By GuruFocus - Investing.com Canada

Nov 13, 2024

Nov 12, 2024

Compugen Reports Strong Q3 2024 Results and Progress - TipRanks

Nov 12, 2024

Nov 12, 2024

Compugen: Q3 Earnings Snapshot - The Washington Post

Nov 12, 2024

Nov 12, 2024

Compugen (CGEN) Q3 Earnings and Revenues Lag Estimates - Yahoo Canada Finance

Nov 12, 2024

Nov 12, 2024

Compugen earnings beat by $0.11, revenue topped estimates - Investing.com India

Nov 12, 2024

Nov 12, 2024

Compugen Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Compugen Surges with $17.1M Revenue, Reports Breakthrough Cancer Drug Progress - StockTitan

Nov 12, 2024

Nov 11, 2024

Compugen to Participate in Stifel 2024 Healthcare Conference - StockTitan

Nov 11, 2024

Nov 10, 2024

Compugen (CGEN) to Release Quarterly Earnings on Tuesday - Defense World

Nov 10, 2024

Nov 08, 2024

Compugen (NASDAQ:CGEN) shareholder returns have been stellar, earning 204% in 1 year - Simply Wall St

Nov 08, 2024

Nov 05, 2024

Compugen Showcases Promising Data on Ovarian Cancer Therapy - TipRanks

Nov 05, 2024

Nov 05, 2024

Compugen's Cancer Drug Combo Shows 17.4% Response Rate in Ovarian Cancer Trial | CGEN Stock News - StockTitan

Nov 05, 2024

Oct 29, 2024

Short Interest in Compugen Ltd. (NASDAQ:CGEN) Decreases By 17.1% - MarketBeat

Oct 29, 2024

Oct 29, 2024

Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - cnhinews.com

Oct 29, 2024

Oct 24, 2024

Compugen Gears Up to Report Q3 Earnings: Here's What to Expect - Yahoo Finance

Oct 24, 2024

Oct 07, 2024

Compugen to Present New Clinical Data at SITC 2024 - StockTitan

Oct 07, 2024

Oct 03, 2024

Compugen Ltd. (NASDAQ:CGEN) Shares Sold by Renaissance Technologies LLC - Defense World

Oct 03, 2024